{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T18:47:17Z","timestamp":1788202037655,"version":"build-2803163510"},"reference-count":48,"publisher":"American Society of Hematology","issue":"13","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,7,14]]},"abstract":"<jats:sec>\n                    <jats:title>Abstract<\/jats:title>\n                    <jats:p>Waldenstr\u00f6m macroglobulinemia (WM) is a rare, indolent B-cell lymphoproliferative disorder, often preceded by a history of immunoglobulin M (IgM) monoclonal gammopathy of undetermined significance (IgM-MGUS). In this retrospective, multicenter study, we collected real-life data from 577 patients with IgM gammopathy (221 symptomatic WM [sWM], 245 asymptomatic WM [aWM], 111 IgM-MGUS) from 22 Spanish centers with a validation cohort of 166 patients (73 sWM, 71 aWM, 22 IgM-MGUS) from the University Hospital of Torino, Italy. The median overall survival (OS) was 126.7 months for the Spanish cohort and 202.8 for the Torino cohort. A multivariate analysis identified age &amp;gt;65 years, male gender, diagnosis of sWM, and \u03b2-2-microglobulin &amp;gt;3 as significant predictors of a shorter OS. In addition, age &amp;gt;65 years, bone marrow (BM) biopsy infiltration, hemoglobin &amp;lt;11.5 g\/dL, and platelets &amp;lt;100 000\/\u03bcL were associated with a shorter time to first treatment (TTFT). Pooling data from both cohorts revealed that a baseline BM quantitative MYD88 L265P to wild-type MYD88 ratio of &amp;gt;0.162 (either by droplet digital polymerase chain reaction [PCR] or quantitative PCR), together with multiparameter flow cytometry (MFC) infiltration &amp;gt;4.39%, had a significant impact on OS and TTFT. The combination of MYD88 and MFC levels enabled stratification of patients into high-, intermediate-, and low-risk groups with patients with high-risk IgM gammopathy showing increased disease-related death in a competing risk analysis.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1182\/bloodadvances.2025018435","type":"journal-article","created":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T20:41:08Z","timestamp":1773952868000},"page":"4519-4532","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":1,"title":["Quantitative MYD88 L265P and flow cytometry levels for outcome determination in IgM gammopathies: the SAL-TO study"],"prefix":"10.1182","volume":"10","author":[{"given":"Irene","family":"Dogliotti","sequence":"first","affiliation":[{"name":"1Division of Hematology, Department of Molecular Biotechnology and Health Sciences, University of Torino, Turin, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5543-5154","authenticated-orcid":false,"given":"Cristina","family":"Jim\u00e9nez","sequence":"additional","affiliation":[{"name":"2Hematology Department, University Hospital of Salamanca, Research Biomedical Institute of Salamanca, Centro de Investigaci\u00f3n Bi\u00f3medica en Red-Cancer and Center for Cancer Research-Instituto de Biolog\u00eda Molecular y Celular del Cancer, Universidad de Salamanca-Consejo Superior de Investigaciones Cient\u00edficas, Salamanca, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veronica","family":"Peri","sequence":"additional","affiliation":[{"name":"1Division of Hematology, Department of Molecular Biotechnology and Health Sciences, University of Torino, Turin, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1336-9603","authenticated-orcid":false,"given":"Martina","family":"Ferrante","sequence":"additional","affiliation":[{"name":"1Division of Hematology, Department of Molecular Biotechnology and Health Sciences, University of Torino, Turin, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Davide","family":"Musto","sequence":"additional","affiliation":[{"name":"1Division of Hematology, Department of Molecular Biotechnology and Health Sciences, University of Torino, Turin, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvio","family":"Mercadante","sequence":"additional","affiliation":[{"name":"1Division of Hematology, Department of Molecular Biotechnology and Health Sciences, University of Torino, Turin, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5643-5917","authenticated-orcid":false,"given":"Gian Maria","family":"Zaccaria","sequence":"additional","affiliation":[{"name":"3Department of Electrical and Information Engineering, Polytechnic University of Bari, Bari, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7626-1563","authenticated-orcid":false,"given":"Marco","family":"Ghislieri","sequence":"additional","affiliation":[{"name":"4PolitoBIOMed Lab and Department of Electronics and Telecommunications, Politecnico di Torino, Turin, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3200-9654","authenticated-orcid":false,"given":"Giulia","family":"Benevolo","sequence":"additional","affiliation":[{"name":"1Division of Hematology, Department of Molecular Biotechnology and Health Sciences, University of Torino, Turin, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5765-0085","authenticated-orcid":false,"given":"Enrique Mar\u00eda","family":"Ocio","sequence":"additional","affiliation":[{"name":"5Hematology Department, University Hospital of Marqu\u00e9s de Valdecilla, Santander, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-2574-1111","authenticated-orcid":false,"given":"Araceli","family":"Rubio","sequence":"additional","affiliation":[{"name":"6Hematology Department, Hospital Miguel Servet, Zaragoza, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0785-6464","authenticated-orcid":false,"given":"Ilda","family":"Murillo","sequence":"additional","affiliation":[{"name":"6Hematology Department, Hospital Miguel Servet, Zaragoza, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4501-9066","authenticated-orcid":false,"given":"Fernando","family":"Escalante","sequence":"additional","affiliation":[{"name":"7Hematology Department, Hospital Complex of Le\u00f3n, Le\u00f3n, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen","family":"Aguilera","sequence":"additional","affiliation":[{"name":"8Hematology Department, Regional Hospital of El Bierzo, Le\u00f3n, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5480-5272","authenticated-orcid":false,"given":"Mateo Ar\u00e1nzazu","family":"Garc\u00eda","sequence":"additional","affiliation":[{"name":"9Hematology Department, General Hospital of Segovia, Segovia, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfonso","family":"Garc\u00eda de Coca","sequence":"additional","affiliation":[{"name":"10Hematology Department, University Clinical Hospital of Valladolid, Valladolid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Hern\u00e1ndez","sequence":"additional","affiliation":[{"name":"11Hematology Department, Virgen de la Concha Hospital, Zamora, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5185-2073","authenticated-orcid":false,"given":"Julio","family":"D\u00e1vila","sequence":"additional","affiliation":[{"name":"12Hematology Department, Nuestra Se\u00f1ora de Sonsoles Hospital, \u00c1vila, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2047-1099","authenticated-orcid":false,"given":"Federica","family":"Cavallo","sequence":"additional","affiliation":[{"name":"1Division of Hematology, Department of Molecular Biotechnology and Health Sciences, University of Torino, Turin, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7535-3861","authenticated-orcid":false,"given":"Noemi","family":"Puig","sequence":"additional","affiliation":[{"name":"2Hematology Department, University Hospital of Salamanca, Research Biomedical Institute of Salamanca, Centro de Investigaci\u00f3n Bi\u00f3medica en Red-Cancer and Center for Cancer Research-Instituto de Biolog\u00eda Molecular y Celular del Cancer, Universidad de Salamanca-Consejo Superior de Investigaciones Cient\u00edficas, Salamanca, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5493-6707","authenticated-orcid":false,"given":"Veronica","family":"Gonz\u00e1lez de la Calle","sequence":"additional","affiliation":[{"name":"2Hematology Department, University Hospital of Salamanca, Research Biomedical Institute of Salamanca, Centro de Investigaci\u00f3n Bi\u00f3medica en Red-Cancer and Center for Cancer Research-Instituto de Biolog\u00eda Molecular y Celular del Cancer, Universidad de Salamanca-Consejo Superior de Investigaciones Cient\u00edficas, Salamanca, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Eugenia","family":"Sarasquete","sequence":"additional","affiliation":[{"name":"2Hematology Department, University Hospital of Salamanca, Research Biomedical Institute of Salamanca, Centro de Investigaci\u00f3n Bi\u00f3medica en Red-Cancer and Center for Cancer Research-Instituto de Biolog\u00eda Molecular y Celular del Cancer, Universidad de Salamanca-Consejo Superior de Investigaciones Cient\u00edficas, Salamanca, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel","family":"Alcoceba","sequence":"additional","affiliation":[{"name":"2Hematology Department, University Hospital of Salamanca, Research Biomedical Institute of Salamanca, Centro de Investigaci\u00f3n Bi\u00f3medica en Red-Cancer and Center for Cancer Research-Instituto de Biolog\u00eda Molecular y Celular del Cancer, Universidad de Salamanca-Consejo Superior de Investigaciones Cient\u00edficas, Salamanca, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3899-5755","authenticated-orcid":false,"given":"Simone","family":"Ragaini","sequence":"additional","affiliation":[{"name":"1Division of Hematology, Department of Molecular Biotechnology and Health Sciences, University of Torino, Turin, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele","family":"Clerico","sequence":"additional","affiliation":[{"name":"1Division of Hematology, Department of Molecular Biotechnology and Health Sciences, University of Torino, Turin, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Consoli","sequence":"additional","affiliation":[{"name":"1Division of Hematology, Department of Molecular Biotechnology and Health Sciences, University of Torino, Turin, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enrico","family":"Amaducci","sequence":"additional","affiliation":[{"name":"1Division of Hematology, Department of Molecular Biotechnology and Health Sciences, University of Torino, Turin, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda","family":"Garc\u00eda-\u00c1lvarez","sequence":"additional","affiliation":[{"name":"2Hematology Department, University Hospital of Salamanca, Research Biomedical Institute of Salamanca, Centro de Investigaci\u00f3n Bi\u00f3medica en Red-Cancer and Center for Cancer Research-Instituto de Biolog\u00eda Molecular y Celular del Cancer, Universidad de Salamanca-Consejo Superior de Investigaciones Cient\u00edficas, Salamanca, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda del Carmen","family":"Chill\u00f3n","sequence":"additional","affiliation":[{"name":"2Hematology Department, University Hospital of Salamanca, Research Biomedical Institute of Salamanca, Centro de Investigaci\u00f3n Bi\u00f3medica en Red-Cancer and Center for Cancer Research-Instituto de Biolog\u00eda Molecular y Celular del Cancer, Universidad de Salamanca-Consejo Superior de Investigaciones Cient\u00edficas, Salamanca, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alejandro","family":"Medina","sequence":"additional","affiliation":[{"name":"2Hematology Department, University Hospital of Salamanca, Research Biomedical Institute of Salamanca, Centro de Investigaci\u00f3n Bi\u00f3medica en Red-Cancer and Center for Cancer Research-Instituto de Biolog\u00eda Molecular y Celular del Cancer, Universidad de Salamanca-Consejo Superior de Investigaciones Cient\u00edficas, Salamanca, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6637-1072","authenticated-orcid":false,"given":"Marcos Gonz\u00e1lez","family":"D\u00edaz","sequence":"additional","affiliation":[{"name":"2Hematology Department, University Hospital of Salamanca, Research Biomedical Institute of Salamanca, Centro de Investigaci\u00f3n Bi\u00f3medica en Red-Cancer and Center for Cancer Research-Instituto de Biolog\u00eda Molecular y Celular del Cancer, Universidad de Salamanca-Consejo Superior de Investigaciones Cient\u00edficas, Salamanca, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5834-9510","authenticated-orcid":false,"given":"Norma Carmen","family":"Guti\u00e9rrez","sequence":"additional","affiliation":[{"name":"2Hematology Department, University Hospital of Salamanca, Research Biomedical Institute of Salamanca, Centro de Investigaci\u00f3n Bi\u00f3medica en Red-Cancer and Center for Cancer Research-Instituto de Biolog\u00eda Molecular y Celular del Cancer, Universidad de Salamanca-Consejo Superior de Investigaciones Cient\u00edficas, Salamanca, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7299-6770","authenticated-orcid":false,"given":"Benedetto","family":"Bruno","sequence":"additional","affiliation":[{"name":"1Division of Hematology, Department of Molecular Biotechnology and Health Sciences, University of Torino, Turin, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1825-1206","authenticated-orcid":false,"given":"Daniela","family":"Drandi","sequence":"additional","affiliation":[{"name":"1Division of Hematology, Department of Molecular Biotechnology and Health Sciences, University of Torino, Turin, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9711-1502","authenticated-orcid":false,"given":"Simone","family":"Ferrero","sequence":"additional","affiliation":[{"name":"1Division of Hematology, Department of Molecular Biotechnology and Health Sciences, University of Torino, Turin, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4120-2787","authenticated-orcid":false,"given":"Ramon","family":"Garc\u00eda-Sanz","sequence":"additional","affiliation":[{"name":"2Hematology Department, University Hospital of Salamanca, Research Biomedical Institute of Salamanca, Centro de Investigaci\u00f3n Bi\u00f3medica en Red-Cancer and Center for Cancer Research-Instituto de Biolog\u00eda Molecular y Celular del Cancer, Universidad de Salamanca-Consejo Superior de Investigaciones Cient\u00edficas, Salamanca, Spain"},{"name":"13Department of Haematology, Gregorio Mara\u00f1\u00f3n General University Hospital, Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","published-online":{"date-parts":[[2026,6,26]]},"reference":[{"issue":"2","key":"2026071409564329500_bib1","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1053\/sonc.2003.50082","article-title":"Clinicopathological definition of Waldenstrom's macroglobulinemia: consensus panel recommendations from the Second International Workshop on Waldenstrom's Macroglobulinemia","volume":"30","author":"Owen","year":"2003","journal-title":"Semin Oncol"},{"issue":"11","key":"2026071409564329500_bib2","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1182\/blood.2022015851","article-title":"The International Consensus Classification of mature lymphoid neoplasms: a report from the Clinical Advisory Committee","volume":"140","author":"Campo","year":"2022","journal-title":"Blood"},{"issue":"8","key":"2026071409564329500_bib3","doi-asserted-by":"crossref","first-page":"3052","DOI":"10.1182\/blood-2008-06-162768","article-title":"Risk of lymphoproliferative disorders among first-degree relatives of lymphoplasmacytic lymphoma\/Waldenstrom macroglobulinemia patients: a population-based study in Sweden","volume":"112","author":"Kristinsson","year":"2008","journal-title":"Blood"},{"issue":"3","key":"2026071409564329500_bib4","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1056\/NEJMoa1709974","article-title":"Long-term follow-up of monoclonal gammopathy of undetermined significance","volume":"378","author":"Kyle","year":"2018","journal-title":"N Engl J Med"},{"issue":"9","key":"2026071409564329500_bib5","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1056\/NEJMoa1200710","article-title":"MYD88 L265P somatic mutation in Waldenstr\u00f6m's macroglobulinemia","volume":"367","author":"Treon","year":"2012","journal-title":"N Engl J Med"},{"issue":"8","key":"2026071409564329500_bib6","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1038\/leu.2013.62","article-title":"MYD88 L265P is a marker highly characteristic of, but not restricted to, Waldenstr\u00f6m's macroglobulinemia","volume":"27","author":"Jim\u00e9nez","year":"2013","journal-title":"Leukemia"},{"issue":"13","key":"2026071409564329500_bib7","doi-asserted-by":"crossref","first-page":"2522","DOI":"10.1182\/blood-2012-09-457101","article-title":"Prevalence and clinical significance of the MYD88 (L265P) somatic mutation in Waldenstrom's macroglobulinemia and related lymphoid neoplasms","volume":"121","author":"Varettoni","year":"2013","journal-title":"Blood"},{"issue":"11","key":"2026071409564329500_bib8","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.1182\/blood-2012-09-454355","article-title":"MYD88 L265P in Waldenstr\u00f6m macroglobulinemia, immunoglobulin M monoclonal gammopathy, and other B-cell lymphoproliferative disorders using conventional and quantitative allele-specific polymerase chain reaction","volume":"121","author":"Xu","year":"2013","journal-title":"Blood"},{"issue":"4","key":"2026071409564329500_bib9","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1111\/bjh.16086","article-title":"A risk-stratification model based on the initial concentration of the serum monoclonal protein and MYD88 mutation status identifies a subset of patients with IgM monoclonal gammopathy of undetermined significance at high risk of progression to Waldenstr\u00f6m macroglobulinaemia or other lymphoproliferative disorders","volume":"187","author":"Varettoni","year":"2019","journal-title":"Br J Haematol"},{"issue":"23","key":"2026071409564329500_bib10","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.1056\/NEJMc1211959","article-title":"MYD88 L265P somatic mutation in IgM MGUS","volume":"367","author":"Landgren","year":"2012","journal-title":"N Engl J Med"},{"issue":"8","key":"2026071409564329500_bib11","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.1038\/leu.2014.65","article-title":"Detection of MYD88 L265P in peripheral blood of patients with Waldenstr\u00f6m's macroglobulinemia and IgM monoclonal gammopathy of undetermined significance","volume":"28","author":"Xu","year":"2014","journal-title":"Leukemia"},{"issue":"6","key":"2026071409564329500_bib12","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.3324\/haematol.2017.186528","article-title":"Highly sensitive MYD88L265P mutation detection by droplet digital polymerase chain reaction in Waldenstr\u00f6m macroglobulinemia","volume":"103","author":"Drandi","year":"2018","journal-title":"Haematologica"},{"issue":"2","key":"2026071409564329500_bib13","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1038\/s41375-022-01762-3","article-title":"Diagnostics in Waldenstr\u00f6m's macroglobulinemia: a consensus statement of the European Consortium for Waldenstr\u00f6m's macroglobulinemia","volume":"37","author":"Dogliotti","year":"2023","journal-title":"Leukemia"},{"key":"2026071409564329500_bib14","doi-asserted-by":"crossref","first-page":"73","DOI":"10.2147\/CMAR.S94059","article-title":"New developments in the management of Waldenstr\u00f6m macroglobulinemia","volume":"9","author":"Abeykoon","year":"2017","journal-title":"Cancer Manag Res"},{"issue":"9","key":"2026071409564329500_bib15","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1001\/jamaoncol.2016.5763","article-title":"Diagnosis and management of Waldenstr\u00f6m macroglobulinemia: Mayo Stratification of Macroglobulinemia and Risk-Adapted Therapy (mSMART) Guidelines 2016","volume":"3","author":"Kapoor","year":"2017","journal-title":"JAMA Oncol"},{"issue":"6","key":"2026071409564329500_bib16","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1111\/bjh.15201","article-title":"Prevalence and survival of smouldering Waldenstr\u00f6m macroglobulinaemia in the United States","volume":"184","author":"Pophali","year":"2019","journal-title":"Br J Haematol"},{"issue":"19","key":"2026071409564329500_bib17","doi-asserted-by":"crossref","first-page":"4462","DOI":"10.1182\/blood-2011-10-384768","article-title":"Progression in smoldering Waldenstrom macroglobulinemia: long-term results","volume":"119","author":"Kyle","year":"2012","journal-title":"Blood"},{"issue":"8","key":"2026071409564329500_bib18","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1200\/JCO.1993.11.8.1553","article-title":"Prognostic factors in Waldenstr\u00f6m's macroglobulinemia: a report of 167 cases","volume":"11","author":"Facon","year":"1993","journal-title":"J Clin Oncol"},{"issue":"10","key":"2026071409564329500_bib19","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1515\/cclm-2016-0748","article-title":"Immunoparesis in IgM gammopathies as a useful biomarker to predict disease progression","volume":"55","author":"Andrade-Campos","year":"2017","journal-title":"Clin Chem Lab Med"},{"issue":"4","key":"2026071409564329500_bib20","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1111\/bjh.15558","article-title":"Prognostic factors and primary treatment for Waldenstr\u00f6m macroglobulinemia - a Swedish Lymphoma Registry study","volume":"183","author":"Brandefors","year":"2018","journal-title":"Br J Haematol"},{"issue":"3","key":"2026071409564329500_bib21","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1046\/j.1365-2141.2001.03144.x","article-title":"Waldenstr\u00f6m macroglobulinaemia: presenting features and outcome in a series with 217 cases","volume":"115","author":"Garc\u00eda-Sanz","year":"2001","journal-title":"Br J Haematol"},{"issue":"2","key":"2026071409564329500_bib22","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.beha.2016.08.014","article-title":"Prognostic factors and indications for treatment of Waldenstr\u00f6m's macroglobulinemia","volume":"29","author":"Kyle","year":"2016","journal-title":"Best Pract Res Clin Haematol"},{"issue":"4","key":"2026071409564329500_bib23","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1182\/blood-2008-07-172080","article-title":"Long-term survival in Waldenstrom macroglobulinemia: 10-year follow-up of Southwest Oncology Group-directed intergroup trial S9003","volume":"113","author":"Dhodapkar","year":"2009","journal-title":"Blood"},{"issue":"18","key":"2026071409564329500_bib24","doi-asserted-by":"crossref","first-page":"4163","DOI":"10.1182\/blood-2008-08-174961","article-title":"International prognostic scoring system for Waldenstrom macroglobulinemia","volume":"113","author":"Morel","year":"2009","journal-title":"Blood"},{"issue":"10","key":"2026071409564329500_bib25","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1016\/j.leukres.2010.04.005","article-title":"Validation of the International Prognostic Scoring System (IPSS) for Waldenstrom's macroglobulinemia (WM) and the importance of serum lactate dehydrogenase (LDH)","volume":"34","author":"Kastritis","year":"2010","journal-title":"Leuk Res"},{"issue":"11","key":"2026071409564329500_bib26","doi-asserted-by":"crossref","first-page":"2654","DOI":"10.1038\/s41375-019-0431-y","article-title":"A revised international prognostic score system for Waldenstr\u00f6m's macroglobulinemia","volume":"33","author":"Kastritis","year":"2019","journal-title":"Leukemia"},{"issue":"16","key":"2026071409564329500_bib27","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1200\/JCO.19.00394","article-title":"Progression risk stratification of asymptomatic Waldenstr\u00f6m macroglobulinemia","volume":"37","author":"Bustoros","year":"2019","journal-title":"J Clin Oncol"},{"issue":"1","key":"2026071409564329500_bib28","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1038\/leu.2013.124","article-title":"Multiparameter flow cytometry for the identification of the Waldenstr\u00f6m's clone in IgM-MGUS and Waldenstr\u00f6m's macroglobulinemia: new criteria for differential diagnosis and risk stratification","volume":"28","author":"Paiva","year":"2014","journal-title":"Leukemia"},{"issue":"9","key":"2026071409564329500_bib29","doi-asserted-by":"crossref","first-page":"e408","DOI":"10.3324\/haematol.2018.190181","article-title":"MYD88 mutated and wild-type Waldenstr\u00f6m's macroglobulinemia: characterization of chromosome 6q gene losses and their mutual exclusivity with mutations in CXCR4","volume":"103","author":"Guerrera","year":"2018","journal-title":"Haematologica"},{"key":"2026071409564329500_bib30","doi-asserted-by":"crossref","first-page":"6728128","DOI":"10.1155\/2018\/6728128","article-title":"Gene expression profile signature of aggressive Waldenstr\u00f6m macroglobulinemia with chromosome 6q deletion","volume":"2018","author":"Sekiguchi","year":"2018","journal-title":"Biomed Res Int"},{"issue":"5","key":"2026071409564329500_bib31","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1111\/bjh.17028","article-title":"6q deletion in Waldenstr\u00f6m macroglobulinaemia negatively affects time to transformation and survival","volume":"192","author":"Garc\u00eda-Sanz","year":"2021","journal-title":"Br J Haematol"},{"issue":"21","key":"2026071409564329500_bib32","doi-asserted-by":"crossref","first-page":"2937","DOI":"10.1182\/bloodadvances.2018022962","article-title":"Insights into the genomic landscape of MYD88 wild-type Waldenstr\u00f6m macroglobulinemia","volume":"2","author":"Hunter","year":"2018","journal-title":"Blood Adv"},{"issue":"12","key":"2026071409564329500_bib33","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.3324\/haematol.2017.172718","article-title":"Pattern of somatic mutations in patients with Waldenstr\u00f6m macroglobulinemia or IgM monoclonal gammopathy of undetermined significance","volume":"102","author":"Varettoni","year":"2017","journal-title":"Haematologica"},{"issue":"8","key":"2026071409564329500_bib34","doi-asserted-by":"crossref","first-page":"dmm050227","DOI":"10.1242\/dmm.050227","article-title":"Clonal architecture and evolutionary history of Waldenstr\u00f6m's macroglobulinemia at the single-cell level","volume":"16","author":"Garc\u00eda-Sanz","year":"2023","journal-title":"Dis Model Mech"},{"issue":"22","key":"2026071409564329500_bib35","doi-asserted-by":"crossref","first-page":"2928","DOI":"10.1182\/blood.V128.22.2928.2928","article-title":"Targeted next generation sequencing identifies novel genetic mutations in patients with Waldenstrom's macroglobulinemia\/lymphoplasmacytic lymphoma or IgM-monoclonal gammopathies of undetermined significance","volume":"128","author":"Varettoni","year":"2016","journal-title":"Blood"},{"issue":"3","key":"2026071409564329500_bib36","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1111\/bjh.15049","article-title":"MYD88 wild-type Waldenstrom macroglobulinaemia: differential diagnosis, risk of histological transformation, and overall survival","volume":"180","author":"Treon","year":"2018","journal-title":"Br J Haematol"},{"issue":"18","key":"2026071409564329500_bib37","doi-asserted-by":"crossref","first-page":"2791","DOI":"10.1182\/blood-2014-01-550905","article-title":"Somatic mutations in MYD88 and CXCR4 are determinants of clinical presentation and overall survival in Waldenstrom macroglobulinemia","volume":"123","author":"Treon","year":"2014","journal-title":"Blood"},{"issue":"21","key":"2026071409564329500_bib38","doi-asserted-by":"crossref","first-page":"2937","DOI":"10.1182\/bloodadvances.2018022962","article-title":"Insights into the genomic landscape of MYD88 wild-type Waldenstr\u00f6m macroglobulinemia","volume":"2","author":"Hunter","year":"2018","journal-title":"Blood Adv"},{"issue":"10","key":"2026071409564329500_bib39","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1080\/17474086.2019.1649132","article-title":"CXCR4 mutations affect presentation and outcomes in patients with Waldenstr\u00f6m macroglobulinemia: a systematic review","volume":"12","author":"Castillo","year":"2019","journal-title":"Expert Rev Hematol"},{"issue":"17","key":"2026071409564329500_bib40","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1182\/blood.2022017235","article-title":"How I use genomics and BTK inhibitors in the treatment of Waldenstr\u00f6m macroglobulinemia","volume":"143","author":"Treon","year":"2024","journal-title":"Blood"},{"issue":"20","key":"2026071409564329500_bib41","doi-asserted-by":"crossref","first-page":"6325","DOI":"10.1158\/1078-0432.CCR-17-0007","article-title":"TP53 mutation and its prognostic significance in Waldenstrom's macroglobulinemia","volume":"23","author":"Poulain","year":"2017","journal-title":"Clin Cancer Res"},{"issue":"suppl 1","key":"2026071409564329500_bib42","doi-asserted-by":"crossref","first-page":"5318","DOI":"10.1182\/blood-2025-5318","article-title":"TP53 mutations in paired bone marrow and cell-free DNA samples of patients with Waldenstr\u00f6m macroglobulinemia or IgM monoclonal gammopathy of undetermined significance prospectively enrolled in the FIL_biowm study of fondazione italiana linfomi","volume":"146","author":"Varettoni","year":"2025","journal-title":"Blood"},{"issue":"2","key":"2026071409564329500_bib43","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1111\/bjh.15560","article-title":"TP53 mutations are associated with mutated MYD88 and CXCR4, and confer an adverse outcome in Waldenstr\u00f6m macroglobulinaemia","volume":"184","author":"Gustine","year":"2019","journal-title":"Br J Haematol"},{"issue":"10","key":"2026071409564329500_bib44","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1097\/PAI.0000000000000020","article-title":"Detection of MYD88 L265P mutation by real-time allele-specific oligonucleotide polymerase chain reaction","volume":"22","author":"Jim\u00e9nez","year":"2014","journal-title":"Appl Immunohistochem Mol Morphol"},{"issue":"9","key":"2026071409564329500_bib45","doi-asserted-by":"crossref","first-page":"1908","DOI":"10.1038\/leu.2012.120","article-title":"EuroFlow antibody panels for standardized n-dimensional flow cytometric immunophenotyping of normal, reactive and malignant leukocytes","volume":"26","author":"van Dongen","year":"2012","journal-title":"Leukemia"},{"issue":"5","key":"2026071409564329500_bib46","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1111\/bjh.18680","article-title":"The Rory Morrison WMUK Registry for Waldenstr\u00f6m macroglobulinaemia: the growth of a national registry for a rare disorder","volume":"201","author":"Uppal","year":"2023","journal-title":"Br J Haematol"},{"issue":"2","key":"2026071409564329500_bib47","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/bjh.18502","article-title":"Prognostic impact of MYD88 and CXCR4 mutations assessed by droplet digital polymerase chain reaction in IgM monoclonal gammopathy of undetermined significance and smouldering Waldenstr\u00f6m macroglobulinaemia","volume":"200","author":"Moreno","year":"2023","journal-title":"Br J Haematol"},{"issue":"4","key":"2026071409564329500_bib48","doi-asserted-by":"crossref","first-page":"969","DOI":"10.3390\/diagnostics12040969","article-title":"Nucleic acid biomarkers in Waldenstr\u00f6m macroglobulinemia and IgM-MGUS: current insights and clinical relevance","volume":"12","author":"Drandi","year":"2022","journal-title":"Diagnostics (Basel)"}],"container-title":["Blood Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/10\/13\/4519\/2530411\/blooda_adv-2025-018435-main.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/10\/13\/4519\/2530411\/blooda_adv-2025-018435-main.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T13:56:55Z","timestamp":1784037415000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article\/10\/13\/4519\/567291\/Quantitative-MYD88-L265P-and-flow-cytometry-levels"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,26]]},"references-count":48,"journal-issue":{"issue":"13","published-print":{"date-parts":[[2026,7,14]]}},"URL":"https:\/\/doi.org\/10.1182\/bloodadvances.2025018435","relation":{},"ISSN":["2473-9529","2473-9537"],"issn-type":[{"value":"2473-9529","type":"print"},{"value":"2473-9537","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,7,14]]},"published":{"date-parts":[[2026,6,26]]}}}